Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
Authors:
- S. S. JickSJS. S. Jick
- R. K. HernandezRHR. K. Hernandez
Open Access
Abstract
F1000Prime Recommended Article: Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.Keywords
This publication has 19 references indexed in Scilit:
- Hormonal contraception and risk of venous thromboembolism: national follow-up studyBMJ, 2009
- Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral ContraceptivesObstetrics & Gynecology, 2007
- The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observationContraception, 2007
- Risk of Venous Thromboembolic Disease Associated With Hormonal Contraceptives and Hormone Replacement TherapyArchives of internal medicine (1960), 2004
- Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptivesThe Lancet, 2001
- Third generation oral contraceptives and risk of venous thrombosis: meta-analysisBMJ, 2001
- Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisBMJ, 2000
- A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptivesBritish Journal of Clinical Pharmacology, 2000
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- ORAL-CONTRACEPTIVES AND NONFATAL VASCULAR-DISEASE1985